Murdocca M, Capuano R, Pucci S, Cicconi R, Polidoro C, Catini A et al (2019) Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model
For PE, SGLT2i vs DPP-4i HR 0.44 (0.300.64), 1.7 vs 3.8/1,000 ( 2.1
No GPhC pharmacy or registered prescriber in the UK will give you this item
Access this article Similar content being viewed by others Data availability My manuscript has no associated data
Compounded Versus Branded GLP-1s The most significant impact GLP-1s have had is on the compounding pharmacy industry, which has nearly doubled its market share due to the initial shortage of drugs
NICE guidelines recommend GLP-1 receptor agonists as add-on therapy for type 2 diabetes when glycaemic targets are not met with other treatments